Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors.

Pharmaceuticals (Basel) · 2024 · PMC11279411 · PMID 39065718

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

The other compounds that weakly inhibited HDAC4 (4135, 36425, and 51936) had IC50 values not much lower than the highest concentration used in the assay (500 μM) and may not be significant inhibitors of either enzyme.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.